MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

Search

Quidel Corp

Fermé

12.89 1.98

Résumé

Variation du prix de l'action

24h

Actuel

Min

12.4

Max

13.31

Chiffres clés

By Trading Economics

Revenu

602M

-131M

Ventes

24M

724M

Marge bénéficiaire

-18.062

Employés

6,500

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+62.63% upside

Dividendes

By Dow Jones

Prochains Résultats

5 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-408M

801M

Ouverture précédente

10.91

Clôture précédente

12.89

Quidel Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

20 avr. 2026, 23:49 UTC

Principaux Événements d'Actualité

New Zealand 1Q Inflation Higher Than Expected

20 avr. 2026, 23:10 UTC

Actions en Tendance

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

20 avr. 2026, 22:53 UTC

Principaux Mouvements du Marché

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

20 avr. 2026, 23:45 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

20 avr. 2026, 23:44 UTC

Market Talk

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

20 avr. 2026, 23:39 UTC

Market Talk

Rio Tinto Posts Strong Start to Year -- Market Talk

20 avr. 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20 avr. 2026, 23:30 UTC

Market Talk

Global Equities Roundup: Market Talk

20 avr. 2026, 23:30 UTC

Market Talk

Super Retail's Earnings Outlook Less Rosy -- Market Talk

20 avr. 2026, 23:09 UTC

Market Talk

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

20 avr. 2026, 22:31 UTC

Acquisitions, Fusions, Rachats

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 avr. 2026, 22:26 UTC

Acquisitions, Fusions, Rachats

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

20 avr. 2026, 22:25 UTC

Acquisitions, Fusions, Rachats

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

20 avr. 2026, 22:25 UTC

Acquisitions, Fusions, Rachats

West African Resources Aims for Acquisition to Be Completed by End-2026

20 avr. 2026, 22:25 UTC

Acquisitions, Fusions, Rachats

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

20 avr. 2026, 22:25 UTC

Acquisitions, Fusions, Rachats

West African Resources Says Acquisition Would Be for A$175 Million

20 avr. 2026, 22:24 UTC

Acquisitions, Fusions, Rachats

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

20 avr. 2026, 22:15 UTC

Acquisitions, Fusions, Rachats

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 avr. 2026, 22:01 UTC

Acquisitions, Fusions, Rachats

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

20 avr. 2026, 21:38 UTC

Market Talk

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

20 avr. 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

20 avr. 2026, 21:24 UTC

Market Talk

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

20 avr. 2026, 21:24 UTC

Market Talk

Global Equities Roundup: Market Talk

20 avr. 2026, 21:13 UTC

Résultats

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

20 avr. 2026, 21:10 UTC

Résultats

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

20 avr. 2026, 21:09 UTC

Résultats

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

20 avr. 2026, 21:08 UTC

Résultats

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

20 avr. 2026, 21:07 UTC

Résultats

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

20 avr. 2026, 21:05 UTC

Résultats

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

20 avr. 2026, 21:05 UTC

Résultats

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Comparaison

Variation de prix

Quidel Corp prévision

Objectif de Prix

By TipRanks

62.63% hausse

Prévisions sur 12 Mois

Moyen 20.67 USD  62.63%

Haut 30 USD

Bas 15 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

1

Achat

3

Maintien

1

Vente

Éléments financiers

Frais Généraux et Administratifs

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

Bénéfice d'exploitation

$

À Propos Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat